Abstract

The mucosal immune system has evolved to protect sites of infection. SARS-CoV-2 impacts both upper and lower respiratory tract leading to mucosal inflammation potentially involving cytokines including IL-1, IL-4, IFNα, IFNγ,sIgA in oral fluids ( OF) of patients with Covid-19 infection.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call